Skin toxicity associated with outcome to erlotinib in non-small cell lung cancer (NSCLC) patients (p) with EGFR mutations in the EURTAC study.

Buges, C; Marti, Am; Rosell, R; Vergnenegre, A; De Marinis, F; Massuti, B; De Castro, J; Gervais, R; Costa, Ec; Moran, T; Santarpia, Mariacarmela; Felip, E; Majem, M; Porta, R; Palmero, R; Drozdowskyj, A; Heidecke, C; Gasco, A; Taron, M; Paz Ares, Lg